1. Market Research
  2. > Cancer Industry

Bladder Cancer Industry, February 2017 Market Reports from Top Publishers

You might be interested in: Cancer, Diagnostics, Therapy, Medical Robot, Cancer Diagnostic, Infectious Disease, Lung Cancer, Interventional Cardiology Device, Lymphoma, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer, Surgical Navigation System, Urology, Urology Device.


 
1-10 of 47 reports for Bladder Cancer

Purchase Reports From Reputable Market Research Publishers

Bladder cancer - Epidemiology Forecast To 2023

Bladder cancer - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Bladder cancer - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Bladder cancer in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). ...

Global Bladder Cancer Partnering 2010 to 2017

Global Bladder Cancer Partnering 2010 to 2017

  • $ 1495
  • Industry report
  • February 2017
  • by Currentpartnering

Summary Provides understanding and access to the bladder cancer partnering deals and agreements entered into by the worlds leading healthcare companies Description The Global Bladder Cancer Partnering ...

Bladder cancer- Market Insights, Epidemiology and Market Forecast-2023

Bladder cancer- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Bladder cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...

Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline ...

 Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2017

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development ...

 Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2017

Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Non Muscle ...

EpiCast Report: Bladder Cancer - Epidemiology Forecast to 2025

EpiCast Report: Bladder Cancer - Epidemiology Forecast to 2025

  • $ 3995
  • Industry report
  • December 2016
  • by GlobalData

EpiCast Report: Bladder Cancer - Epidemiology Forecast to 2025 Summary Bladder cancer is a commonly diagnosed cancer and causes significant numbers of cancer deaths worldwide. The major risk factors fo ...

Muscle Invasive Bladder Cancer (MIBC) - Pipeline Review, H2 2016

Muscle Invasive Bladder Cancer (MIBC) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Muscle Invasive Bladder Cancer (MIBC) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Muscle Invasive Bladder Cancer (MIBC) – Pipeline ...

Bladder Cancer - Pipeline Review, H2 2016

Bladder Cancer - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Bladder Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Bladder Cancer – Pipeline Review, H2 2016, provides an overview ...

Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H2, 2016

Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H2, 2016" ...

About 2400 reports for Bladder Cancer

Download Unlimited Documents from Trusted Public Sources

Therapy Market and Chemotherapy Market in the US

  • June 2015
    256 pages
  • Therapy  

    Chemotherapy  

    Oncology  

  • United States  

View report >

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.